Barriers to typhoid fever vaccine access in endemic countries

M Imran Khan,1 Carlos Franco-Paredes,2,3 Sushant Sahastrabuddhe,4 R Leon Ochiai,5 Vittal Mogasale,4 Bradford D Gessner6 1Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan; 2Hospital Infantil de México, Federico Gómez, México DF., Mexico; 3Phoebe Putney Memori...

Full description

Bibliographic Details
Main Authors: Khan MI, Franco-Paredes C, Sahastrabuddhe S, Ochiai RL, Mogasale V, BD Gessner
Format: Article in Journal/Newspaper
Language:English
Published: Dove Medical Press 2017
Subjects:
Online Access:https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57
_version_ 1821839262072438784
author Khan MI
Franco-Paredes C
Sahastrabuddhe S
Ochiai RL
Mogasale V
BD Gessner
author_facet Khan MI
Franco-Paredes C
Sahastrabuddhe S
Ochiai RL
Mogasale V
BD Gessner
author_sort Khan MI
collection Directory of Open Access Journals: DOAJ Articles
description M Imran Khan,1 Carlos Franco-Paredes,2,3 Sushant Sahastrabuddhe,4 R Leon Ochiai,5 Vittal Mogasale,4 Bradford D Gessner6 1Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan; 2Hospital Infantil de México, Federico Gómez, México DF., Mexico; 3Phoebe Putney Memorial Hospital, Albany, GA, USA; 4International Vaccine Institute, Seoul, Republic of Korea; 5Sanofi Pasteur, Lyon, 6Agence de Médecine Preventive, Ferney-Voltaire, France Abstract: Typhoid vaccines have been available as a means of disease control and prevention since 1896; however, their use as a routine tool for disease prevention in endemic settings has been hampered because of: 1) insufficient data on disease burden particularly regarding the lack of health care access in the poorest communities affected by typhoid; 2) limitations of the typhoid vaccine, such as shorter duration of protection, moderate efficacy in young children, and no efficacy for infants; 3) inadequate evidence on potential economic benefits when used for a larger population; 4) neglect in favor of alternative interventions that require massive infrastructure; 5) no financial support or commitment regarding vaccine delivery cost; 6) ambivalence about whether to invest in water and sanitation hygiene versus the vaccine; and 7) clarity on global policy for country adoption. If current typhoid-protein conjugate vaccines live up to their promise of higher efficacy, longer duration of protection, and efficacy in young children, typhoid vaccine use will be a critical component of short- and medium-term disease control strategies. Typhoid control could be accelerated if the global framework includes plans for accelerated introduction of the conjugate typhoid vaccine in developing countries. Keywords: typhoid fever, vaccines, policy, endemic countries, barriers, immunization
format Article in Journal/Newspaper
genre Arctic
genre_facet Arctic
geographic Arctic
Pasteur
geographic_facet Arctic
Pasteur
id ftdoajarticles:oai:doaj.org/article:52f6043d51624afd8581a1d6c5d53b57
institution Open Polar
language English
long_lat ENVELOPE(140.099,140.099,-66.625,-66.625)
op_collection_id ftdoajarticles
op_relation https://www.dovepress.com/barriers-to-typhoid-fever-vaccine-access-in-endemic-countries-peer-reviewed-article-RRTM
https://doaj.org/toc/1179-7282
1179-7282
https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57
op_source Research and Reports in Tropical Medicine, Vol Volume 8, Pp 37-44 (2017)
publishDate 2017
publisher Dove Medical Press
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:52f6043d51624afd8581a1d6c5d53b57 2025-01-16T20:44:21+00:00 Barriers to typhoid fever vaccine access in endemic countries Khan MI Franco-Paredes C Sahastrabuddhe S Ochiai RL Mogasale V BD Gessner 2017-03-01T00:00:00Z https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 EN eng Dove Medical Press https://www.dovepress.com/barriers-to-typhoid-fever-vaccine-access-in-endemic-countries-peer-reviewed-article-RRTM https://doaj.org/toc/1179-7282 1179-7282 https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 Research and Reports in Tropical Medicine, Vol Volume 8, Pp 37-44 (2017) typhoid fever vaccines policy endemic countries barriers immunization Arctic medicine. Tropical medicine RC955-962 article 2017 ftdoajarticles 2022-12-31T03:46:54Z M Imran Khan,1 Carlos Franco-Paredes,2,3 Sushant Sahastrabuddhe,4 R Leon Ochiai,5 Vittal Mogasale,4 Bradford D Gessner6 1Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan; 2Hospital Infantil de México, Federico Gómez, México DF., Mexico; 3Phoebe Putney Memorial Hospital, Albany, GA, USA; 4International Vaccine Institute, Seoul, Republic of Korea; 5Sanofi Pasteur, Lyon, 6Agence de Médecine Preventive, Ferney-Voltaire, France Abstract: Typhoid vaccines have been available as a means of disease control and prevention since 1896; however, their use as a routine tool for disease prevention in endemic settings has been hampered because of: 1) insufficient data on disease burden particularly regarding the lack of health care access in the poorest communities affected by typhoid; 2) limitations of the typhoid vaccine, such as shorter duration of protection, moderate efficacy in young children, and no efficacy for infants; 3) inadequate evidence on potential economic benefits when used for a larger population; 4) neglect in favor of alternative interventions that require massive infrastructure; 5) no financial support or commitment regarding vaccine delivery cost; 6) ambivalence about whether to invest in water and sanitation hygiene versus the vaccine; and 7) clarity on global policy for country adoption. If current typhoid-protein conjugate vaccines live up to their promise of higher efficacy, longer duration of protection, and efficacy in young children, typhoid vaccine use will be a critical component of short- and medium-term disease control strategies. Typhoid control could be accelerated if the global framework includes plans for accelerated introduction of the conjugate typhoid vaccine in developing countries. Keywords: typhoid fever, vaccines, policy, endemic countries, barriers, immunization Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Pasteur ENVELOPE(140.099,140.099,-66.625,-66.625)
spellingShingle typhoid fever
vaccines
policy
endemic countries
barriers
immunization
Arctic medicine. Tropical medicine
RC955-962
Khan MI
Franco-Paredes C
Sahastrabuddhe S
Ochiai RL
Mogasale V
BD Gessner
Barriers to typhoid fever vaccine access in endemic countries
title Barriers to typhoid fever vaccine access in endemic countries
title_full Barriers to typhoid fever vaccine access in endemic countries
title_fullStr Barriers to typhoid fever vaccine access in endemic countries
title_full_unstemmed Barriers to typhoid fever vaccine access in endemic countries
title_short Barriers to typhoid fever vaccine access in endemic countries
title_sort barriers to typhoid fever vaccine access in endemic countries
topic typhoid fever
vaccines
policy
endemic countries
barriers
immunization
Arctic medicine. Tropical medicine
RC955-962
topic_facet typhoid fever
vaccines
policy
endemic countries
barriers
immunization
Arctic medicine. Tropical medicine
RC955-962
url https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57